Today’s Opinions: FDA Approval Rules And Concerns About Cancer Drug; Precedence For Health Repeal; The Need To Understand Health Disparities
Avastin Shouldn't Make The FDA Give Up On 'Accelerated Approval' Of Drugs The Los Angeles Times
Called 'accelerated approval,' this 'quick-on, quick-off' mechanism for medicines to reach the marketplace can work to the advantage of drug companies and needy patients alike (Henry I. Miller and Jeff Stier, 8/17).
Repair? No, Repeal ObamaCare Fremont (Neb.) Tribune
There's a sense of fait accompli in Washington policy circles, a fatalistic resignation to some historically inevitable implementation of this behemoth over the next eight years. Well, not so fast. Take a trip down memory lane (Robert Moffit, 8/16).
Why ObamaCare Must Be Repealed Real Clear Politics
The Canadian experience offers a preview of what Obamacare has in store for the United States (Sally Pipes, 8/17).
One More Divide To Bridge The Kansas City Star
Health disparities between African-Americans and whites in some areas are narrowing. In others, the differences are widening. The issue of racial and ethnic health disparities has become one of the most pressing problems for the health care system in the United States today (Steve Penn, 8/16).
The Real Price Of Universal Health Care Forbes
The new 1099-reporting rules [in the health law] will most certainly be a hassle. But by taking steps now to improve the quality and efficiency of spend and supplier data, you can get in front of them and handle things in stride. (Tim Minahan, 8/17).
